Research ArticleNeuropharmacology
Open Access
Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction
Yong-Xin Li, Jia-Ying Yang, Miguel Alcantara, Grigor Abelian, Ashutosh Kulkarni, Ursula Staubli and Alan C. Foster
Journal of Pharmacology and Experimental Therapeutics November 2018, 367 (2) 292-301; DOI: https://doi.org/10.1124/jpet.118.251116
Yong-Xin Li
Department of Biological Sciences, Allergan, Inc., Irvine, California
Jia-Ying Yang
Department of Biological Sciences, Allergan, Inc., Irvine, California
Miguel Alcantara
Department of Biological Sciences, Allergan, Inc., Irvine, California
Grigor Abelian
Department of Biological Sciences, Allergan, Inc., Irvine, California
Ashutosh Kulkarni
Department of Biological Sciences, Allergan, Inc., Irvine, California
Ursula Staubli
Department of Biological Sciences, Allergan, Inc., Irvine, California
Alan C. Foster
Department of Biological Sciences, Allergan, Inc., Irvine, California
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
Effects of ASCT1/ASCT2 Transporter Inhibitors In Vivo
Yong-Xin Li, Jia-Ying Yang, Miguel Alcantara, Grigor Abelian, Ashutosh Kulkarni, Ursula Staubli and Alan C. Foster
Journal of Pharmacology and Experimental Therapeutics November 1, 2018, 367 (2) 292-301; DOI: https://doi.org/10.1124/jpet.118.251116
Research ArticleNeuropharmacology
Effects of ASCT1/ASCT2 Transporter Inhibitors In Vivo
Yong-Xin Li, Jia-Ying Yang, Miguel Alcantara, Grigor Abelian, Ashutosh Kulkarni, Ursula Staubli and Alan C. Foster
Journal of Pharmacology and Experimental Therapeutics November 1, 2018, 367 (2) 292-301; DOI: https://doi.org/10.1124/jpet.118.251116
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement